+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
JAGSNPHARM

Jagsonpal Pharmaceuticals Share Price

₹218.37 -0.73 (-0.33%)
40.88% Gain from 52W Low

16 Oct, 2026 3:57 PM (IST)

Jagsonpal Pharmaceuticals live price: ₹218.37. It opened at ₹221 vs previous close ₹219; intraday high/low: ₹222/₹217. The 50 & 200 DMA stand at ₹230.00/₹218.60.

Jagsonpal Pharmaceuticals Performance

  • Today's Low
  • ₹217
  • Today's High
  • ₹222
  • 52 Week Low
  • ₹155
  • 52 Week High
  • ₹265
  • Open Price₹221
  • Previous Close₹219
  • Volume49,446
  • 50 DMA₹230.00
  • 100 DMA₹225.40
  • 200 DMA₹218.60

Jagsonpal Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -4.34%
  • Over 3 Month -3.75%
  • Over 6 Month + 12.28%
  • Over 1 Year -0.94%

Smart Investing Starts Here Start SIP with Jagsonpal Pharmaceuticals for Steady Growth!

Invest Now

Jagsonpal Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.7
  • PEG Ratio
  • -1.3
  • Market Cap Cr
  • 1,440
  • P/B Ratio
  • 5
  • Average True Range
  • 8.6
  • EPS
  • 6.9
  • Dividend Yield
  • 1.8
  • MACD Signal
  • -3.3
  • RSI
  • 36.17
  • MFI
  • 29.63

Latest Stock News Updates

Jagsonpal Pharmaceuticals Ltd - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate in terms of Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

Subsequent to fulfilment of the Conditions Precedent under the BTA the transactions has been consummated with effect from today i.e. October 01, 2026.

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement regarding transfer of Shares to IEPF and Notice of loss of share Certificate

Jagsonpal Pharmaceuticals Financials

Jagsonpal Pharmaceuticals Technicals

EMA & SMA

Current Price
₹218.37
-0.73 (-0.33%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹228.50
  • 50 Day
  • ₹230.00
  • 100 Day
  • ₹225.40
  • 200 Day
  • ₹218.60

Resistance and Support

219.26 Pivot Speed
  • R3 226.40
  • R2 224.30
  • R1 221.30
  • S1 216.30
  • S2 214.20
  • S3 211.30

Jagsonpal Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-29 Quarterly Results
2026-04-27 Audited Results & Final Dividend
2026-03-12 Buy Back of Shares
2026-01-21 Quarterly Results
2025-11-03 Quarterly Results
Date Purpose Remarks
2026-09-04 FINAL Rs.4.00 per share(200%)Final Dividend
2025-09-12 FINAL Rs.2.50 per share(125%)Final Dividend
2024-09-06 FINAL Rs.5.00 per share(100%)Final Dividend
2023-08-21 FINAL Rs.5.00 per share(100%)Dividend
2021-11-01 INTERIM Rs.4.00 per share(80%)Interim Dividend
View Jagsonpal Pharmaceuticals Dividend History Arrow
Date Purpose Remarks
2025-01-08 Split Stock split from Rs. 5/- to Rs. 2/-.
2004-07-28 Split Subdivision of equity shares from Rs. 10/- to Rs. 5/-

Jagsonpal Pharmaceuticals Shareholding Pattern

69.05%
28.04%
2.3%
0.62%

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients. View More
  • NSE Symbol
  • JAGSNPHARM
  • BSE Symbol
  • 507789
  • ISIN
  • INE048B01035

Similar Stocks to Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals FAQs

Jagsonpal Pharmaceuticals share price is ₹218 As on 18 October, 2026 | 03:14

The Market Cap of Jagsonpal Pharmaceuticals is ₹1440.3 Cr As on 18 October, 2026 | 03:14

The P/E ratio of Jagsonpal Pharmaceuticals is 31.7 As on 18 October, 2026 | 03:14

The PB ratio of Jagsonpal Pharmaceuticals is 5 As on 18 October, 2026 | 03:14

The 52 week High & Low of Jagsonpal Pharmaceuticals is ₹264.5/₹155 respectively As on 18 October, 2026 | 03:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23